Quick Answer
Outlook Therapeutics, Inc. reported Net Income of -$62.42 million for fiscal year 2025.
Outlook Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$62.42M | +17.2% |
| 2024 | -$75.37M | -27.8% |
| 2023 | -$58.98M | +10.7% |
| 2022 | -$66.05M | -24.2% |
| 2021 | -$53.16M | -50.9% |
| 2020 | -$35.24M | -2.1% |
| 2019 | -$34.52M | -14.7% |
| 2018 | -$30.09M | +22.5% |
| 2017 | -$38.85M | +27.1% |
| 2016 | -$53.30M | -12.5% |
| 2015 | -$47.39M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$23.06M | -232.7% | -14.4% |
| June 30, 2025 | -$20.15M | -145.4% | +56.5% |
| March 31, 2025 | -$46.36M | +59.4% | -366.8% |
| December 31, 2024 | $17.38M | +255.5% | -60.9% |
| June 30, 2024 | $44.41M | +314.8% | +138.9% |
| March 31, 2024 | -$114.29M | -1617.5% | -922.4% |
| December 31, 2023 | -$11.18M | +40.1% | +45.9% |
| June 30, 2023 | -$20.68M | -17.9% | -210.7% |
- Outlook Therapeutics, Inc. showed an increase of +17.2% in Net Income compared to the prior fiscal year.
- Over the 2015–2025 period, Outlook Therapeutics, Inc.’s net income has declined by 31.7% (from -$47.39 million to -$62.42 million).
- The most recent figure is from Outlook Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 19, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: